These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15201550)

  • 1. Plasma concentration of urotensin II is raised in hypertension.
    Cheung BM; Leung R; Man YB; Wong LY
    J Hypertens; 2004 Jul; 22(7):1341-4. PubMed ID: 15201550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of cerebrospinal fluid and plasma urotensin II concentrations in normotensive and hypertensive patients undergoing urological surgery during spinal anesthesia: a pilot study.
    Thompson JP; Watt P; Sanghavi S; Strupish JW; Lambert DG
    Anesth Analg; 2003 Nov; 97(5):1501-1503. PubMed ID: 14570674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between human urotensin II and essential hypertension--a 1:1 matched case-control study.
    Peng H; Zhang M; Cai X; Olofindayo J; Tan A; Zhang Y
    PLoS One; 2013; 8(12):e81764. PubMed ID: 24339964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum salusin-alpha levels are decreased and correlated negatively with carotid atherosclerosis in essential hypertensive patients.
    Watanabe T; Suguro T; Sato K; Koyama T; Nagashima M; Kodate S; Hirano T; Adachi M; Shichiri M; Miyazaki A
    Hypertens Res; 2008 Mar; 31(3):463-8. PubMed ID: 18497465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased human urotensin II levels are correlated with carotid atherosclerosis in essential hypertension.
    Suguro T; Watanabe T; Ban Y; Kodate S; Misaki A; Hirano T; Miyazaki A; Adachi M
    Am J Hypertens; 2007 Feb; 20(2):211-7. PubMed ID: 17261470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise urotensin II dynamics in myocardial infarction survivors with and without hypertension.
    Rdzanek A; Filipiak KJ; Karpiński G; Grabowski M; Opolski G
    Int J Cardiol; 2006 Jun; 110(2):175-8. PubMed ID: 16198012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum urotensin II levels in patients with non-dipper hypertension.
    Erbay AR; Meric M; Alacam H; Zengin H; Akin F; Okuyucu A; Yuksel S; Soylu K; Gedikli O
    Clin Exp Hypertens; 2013; 35(7):506-11. PubMed ID: 23301552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological effects of urotensins. IV. Blood pressure-lowering effects of urotensin I in spontaneously hypertensive rats.
    Medakovic M; Lederis K
    Pharmacology; 1975; 13(5):433-40. PubMed ID: 1208646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension.
    Geroldi D; Falcone C; Emanuele E; D'Angelo A; Calcagnino M; Buzzi MP; Scioli GA; Fogari R
    J Hypertens; 2005 Sep; 23(9):1725-9. PubMed ID: 16093918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No effect on central or peripheral blood pressure of systemic urotensin II infusion in humans.
    Affolter JT; Newby DE; Wilkinson IB; Winter MJ; Balment RJ; Webb DJ
    Br J Clin Pharmacol; 2002 Dec; 54(6):617-21. PubMed ID: 12492609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urotensin-II, oxidative stress, and inflammation increase in hypertensive and resistant hypertensive patients.
    Guler EM; Gokce M; Bacaksiz A; Kocyigit A
    Clin Exp Hypertens; 2021 Apr; 43(3):211-216. PubMed ID: 33172302
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma urotensin II in heart failure.
    Richards AM; Nicholls MG; Lainchbury JG; Fisher S; Yandle TG
    Lancet; 2002 Aug; 360(9332):545-6. PubMed ID: 12241661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the effect of adrenomedulin and urotensin-II on pulmonary hypertension of patients with congenital heart disease].
    Wang T; Li SX; Zhang XQ; Gu XH; Song Y; Zhang G; Wu SM
    Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(38):2691-5. PubMed ID: 16324296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma brain natriuretic peptide and C-type natriuretic peptide in essential hypertension.
    Cheung BM; Brown MJ
    J Hypertens; 1994 Apr; 12(4):449-54. PubMed ID: 8064169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urotensin-II system in genetic control of blood pressure and renal function.
    Debiec R; Christofidou P; Denniff M; Bloomer LD; Bogdanski P; Wojnar L; Musialik K; Charchar FJ; Thompson JR; Waterworth D; Song K; Vollenweider P; Waeber G; Zukowska-Szczechowska E; Samani NJ; Lambert D; Tomaszewski M
    PLoS One; 2013; 8(12):e83137. PubMed ID: 24391740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of urotensin II in patients on dialysis.
    Totsune K; Takahashi K; Arihara Z; Sone M; Satoh F; Ito S; Kimura Y; Sasano H; Murakami O
    Lancet; 2001 Sep; 358(9284):810-1. PubMed ID: 11564491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes.
    Suguro T; Watanabe T; Kodate S; Xu G; Hirano T; Adachi M; Miyazaki A
    Clin Sci (Lond); 2008 Dec; 115(11):327-34. PubMed ID: 18338983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma urotensin II as a marker for severity of rheumatic valve disease.
    Ozer O; Davutoglu V; Ercan S; Akcay M; Sari I; Sucu M; Celik A; Aksoy N; Cicek H; Al B
    Tohoku J Exp Med; 2009 May; 218(1):57-62. PubMed ID: 19398874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the urotensin receptor antagonist palosuran in hypertensive patients with type 2 diabetic nephropathy.
    Vogt L; Chiurchiu C; Chadha-Boreham H; Danaietash P; Dingemanse J; Hadjadj S; Krum H; Navis G; Neuhart E; Parvanova AI; Ruggenenti P; Woittiez AJ; Zimlichman R; Remuzzi G; de Zeeuw D;
    Hypertension; 2010 May; 55(5):1206-9. PubMed ID: 20231521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urotensin-II levels in acute coronary syndromes.
    Joyal D; Huynh T; Aiyar N; Guida B; Douglas S; Giaid A
    Int J Cardiol; 2006 Mar; 108(1):31-5. PubMed ID: 16516696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.